版本:
中国

BRIEF-Argenx presents update on phase I data from ARGX-110 expansion study

June 14 ARGENX NV

* REG-ARGENX PRESENTS UPDATE ON PHASE I DATA FROM ARGX-110 EXPANSION STUDY IN PATIENTS WITH CUTANEOUS T-CELL LYMPHOMAS AT THE INTERNATIONAL CONFERENCE OF MALIGNANT LYMPHOMA (ICML) Source text for Eikon: Further company coverage: (Gdynia Newsroom)

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐